Abstract
Breast cancer is a heterogeneous disease with a varied clinical outcome, underscoring the need for the use of reliable predictive and prognostic biomarkers. Prognostic markers help in estimating clinical outcome, regardless of treatment modality. Predictive markers are required for optimal therapeutic decision making and are indexes of the response of a patient to a specific therapeutic intervention. They help determine the sensitivity or resistance of a tumor to a particular therapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSuggested Reading
Harris JR, Lippman ME, Kent Osborne C, Morrow M. Diseases of the Breast, Fifth Edition, Wolters Kluwer Health, 2014.
Kuerer H. Kuerer’s breast surgical oncology. New York: McGraw Hill Publishers; 2010.
O’Malley FP, Pinder SE. Breast pathology. Edinburgh: Churchill Livingstone; 2006.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer India
About this chapter
Cite this chapter
Selvi, R. (2015). Breast Pathology: Conventional Prognostic Markers. In: Breast Diseases. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2077-0_25
Download citation
DOI: https://doi.org/10.1007/978-81-322-2077-0_25
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2076-3
Online ISBN: 978-81-322-2077-0
eBook Packages: MedicineMedicine (R0)